Fundamentals of Viral Structure and Pathogenesis
Understanding how viruses cause disease requires a solid grasp of their structural components, replication strategies, and the host factors that influence infection severity. This course…

In the classic experiment by Fraenkel‑Conrat and Sanger, what conclusion was drawn about the genetic material of TMV?
Why do enveloped viruses lose infectivity after treatment with detergents?
A virus with a single‑stranded RNA genome of negative polarity requires which enzymatic activity to produce mRNA?
Which structural feature distinguishes adenoviruses from influenza viruses in electron micrographs?
During viral entry, clathrin‑mediated endocytosis leads to which critical intracellular event for many RNA viruses?
Which of the following statements best explains why only certain cells in an animal can produce a given virus?
In the Baltimore classification, which class includes retroviruses such as HIV?
What is the primary reason that viral particles are invisible under a light microscope but visible under electron microscopy?
Which step in the viral life cycle is directly affected by interferon‑γ released by CD8⁺ T cells?
Fundamentals of Viral Structure and Pathogenesis
Understanding how viruses cause disease requires a solid grasp of their structural components, replication strategies, and the host factors that influence infection severity. This course synthesizes key concepts drawn from a quiz on viral fundamentals, providing a comprehensive, SEO‑friendly overview for students, educators, and researchers.
1. Determinants of Viral Disease Severity
The severity of a viral infection in an individual is not dictated by the size of the viral genome, the presence of an envelope, or the sheer number of virions present. Instead, the number of competent host cells capable of producing virions is the primary factor. Cells that support viral replication provide the necessary machinery—ribosomes, polymerases, and metabolic resources—to generate new virus particles. When a virus infects a tissue with abundant permissive cells, the resulting viral load can be high, leading to more severe clinical outcomes.
- Permissive cells: Cells that express the receptors and intracellular factors required for the virus life cycle.
- Productive infection: Successful synthesis of viral components and assembly of infectious virions.
- Host immune response: While crucial for clearance, the immune response alone does not determine initial disease severity.
2. Genetic Material Determines Viral Phenotype
The classic Fraenkel‑Conrat and Sanger experiment with tobacco mosaic virus (TMV) demonstrated that RNA, not the protein coat, determines the viral phenotype. By exchanging the RNA of one TMV strain with the protein coat of another, researchers showed that the resulting virus exhibited the traits of the RNA donor. This pivotal finding established RNA as the genetic material for many viruses and underscored the concept that the viral genome encodes all information needed for replication and pathogenicity.
3. Role of the Lipid Envelope in Infectivity
Enveloped viruses, such as influenza and HIV, acquire a lipid bilayer from the host cell membrane during budding. This envelope contains viral glycoproteins essential for attachment and entry. Detergents disrupt the lipid envelope, rendering the virus non‑infectious because the glycoproteins can no longer mediate fusion with host membranes. The underlying capsid and genome remain intact, but without the envelope, the virus cannot deliver its genetic material into the target cell.
- Detergent action: Solubilizes lipids, causing loss of envelope integrity.
- Consequences: Inability to bind receptors, failure of membrane fusion, loss of infectivity.
4. Replication of Negative‑Sense Single‑Stranded RNA Viruses
Viruses with a negative‑sense single‑stranded RNA (ssRNA‑) genome cannot be directly translated by host ribosomes. They must first synthesize a complementary positive‑sense mRNA. This conversion is performed by an RNA‑dependent RNA polymerase (RdRp), also called transcriptase, which the virus packages within the virion. Once inside the host cell, RdRp generates mRNA, which can then be translated into viral proteins.
- Examples: Influenza virus, Rabies virus, Vesicular stomatitis virus.
- Key enzyme: Viral RdRp, not host DNA‑dependent RNA polymerase.
5. Distinguishing Viral Morphologies
Electron microscopy reveals distinct structural signatures that differentiate virus families. Adenoviruses display a regular icosahedral geometry with triangular faces, whereas influenza viruses possess a pleomorphic, enveloped, and helical nucleocapsid. Recognizing these morphological differences aids in rapid identification and classification of viral pathogens.
- Adenovirus: Non‑enveloped, icosahedral capsid (~90 nm), double‑stranded DNA genome.
- Influenza virus: Enveloped, segmented negative‑sense ssRNA, surface spikes (hemagglutinin and neuraminidase).
6. Clathrin‑Mediated Endocytosis and Viral Entry
Many RNA viruses exploit clathrin‑mediated endocytosis to gain entry into host cells. After internalization, the endosome undergoes acidification, which triggers conformational changes in viral envelope proteins, leading to fusion of the viral and endosomal membranes. This fusion releases the viral genome into the cytoplasm, initiating replication. The acidified environment is therefore a critical intracellular cue for successful infection.
- Acidification → Fusion → Genome release.
- Failure to acidify (e.g., by lysosomotropic agents) can block infection.
7. Cellular Tropism and Enzymatic Repertoire
Only certain cells within an animal can produce a given virus because only cells expressing the necessary enzymatic repertoire can synthesize viral components. This includes specific polymerases, proteases, and host factors that the virus hijacks. While surface receptors determine entry, the downstream replication steps depend on intracellular machinery. For example, retroviruses require host reverse transcriptase activity, whereas DNA viruses need cellular DNA polymerases for genome replication.
- Receptor presence = entry potential.
- Enzymatic compatibility = productive infection.
8. Baltimore Classification – Class VI Retroviruses
The Baltimore classification system groups viruses based on genome type and replication strategy. Class VI comprises retroviruses such as HIV, which possess an RNA genome but replicate through a DNA intermediate using reverse transcriptase. This unique pathway distinguishes them from other RNA viruses (Classes III, IV, and V) and DNA viruses (Classes I and II).
- Class I: dsDNA viruses (e.g., Adenovirus).
- Class III: dsRNA viruses (e.g., Reovirus).
- Class IV: (+)ssRNA viruses (e.g., Picornavirus).
- Class VI: Retroviruses – RNA → DNA via reverse transcriptase.
9. Integrating Concepts: From Structure to Pathogenesis
By linking structural features, replication mechanisms, and host cell factors, we can predict viral behavior and disease outcomes. For instance, an enveloped virus with a fragile lipid membrane (e.g., influenza) is highly susceptible to detergents, whereas a non‑enveloped icosahedral virus (e.g., adenovirus) resists such treatments but may rely on specific intracellular enzymes for replication. Understanding these relationships is essential for developing antiviral strategies, vaccine design, and diagnostic tools.
10. Key Takeaways
- The number of permissive host cells is the primary determinant of infection severity.
- RNA, not protein, encodes the viral phenotype, as shown by TMV experiments.
- Detergents inactivate enveloped viruses by disrupting their lipid envelope.
- Negative‑sense ssRNA viruses require an RNA‑dependent RNA polymerase to produce mRNA.
- Adenoviruses are icosahedral; influenza viruses are enveloped and helical.
- Acidification of endosomes is crucial for membrane fusion during clathrin‑mediated entry.
- Cellular enzymatic repertoire, not just receptors, dictates viral production.
- Retroviruses belong to Baltimore Class VI, using reverse transcriptase.
Mastering these fundamentals equips learners with the analytical tools needed to explore advanced topics such as viral evolution, antiviral drug development, and emerging infectious diseases.
